Haddad Sara F, Lahr Brian D, El Sabbagh Abdallah, Wilson Walter R, Chesdachai Supavit, DeSimone Daniel C, Baddour Larry M
Department of Medicine, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA.
Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.
Catheter Cardiovasc Interv. 2024 Feb;103(3):464-471. doi: 10.1002/ccd.30958. Epub 2024 Jan 29.
Given the challenges of conventional therapies in managing right-sided infective endocarditis (RSIE), percutaneous mechanical aspiration (PMA) of vegetations has emerged as a novel treatment option. Data on trends, characteristics, and outcomes of PMA, however, have largely been limited to case reports and case series.
The aim of the current investigation was to provide a descriptive analysis of PMA in the United States and to profile the frequency of PMA with a temporal analysis and the patient cohort.
The International Classification of Diseases, 10th Revision codes were used to identify patients with RSIE in the national (nationwide) inpatient sample (NIS) database between 2016 and 2020. The clinical characteristics and temporal trends of RSIE hospitalizations in patients who underwent PMA was profiled.
An estimated 117,955 RSIE-related hospital admissions in the United States over the 5-year study period were estimated and 1675 of them included PMA. Remarkably, the rate of PMA for RSIE increased 4.7-fold from 2016 (0.56%) to 2020 (2.62%). Patients identified with RSIE who had undergone PMA were young (medial age 36.5 years) and had few comorbid conditions (median Charlson Comorbidity Index, 0.6). Of note, 36.1% of patients had a history of hepatitis C infection, while only 9.9% of patients had a cardiovascular implantable electronic device. Staphylococcus aureus was the predominant (61.8%) pathogen. Concomitant transvenous lead extraction and cardiac valve surgery during the PMA hospitalization were performed in 18.2% and 8.4% of admissions, respectively. The median hospital stay was 19.0 days, with 6.0% in-hospital mortality.
The marked increase in the number of PMA procedures in the United States suggests that this novel treatment option has been embraced as a useful tool in select cases of RSIE. More work is needed to better define indications for the procedure and its efficacy and safety.
鉴于传统疗法在治疗右侧感染性心内膜炎(RSIE)方面存在挑战,经皮机械抽吸(PMA)赘生物已成为一种新的治疗选择。然而,关于PMA的趋势、特征和结局的数据在很大程度上仅限于病例报告和病例系列。
本研究的目的是对美国的PMA进行描述性分析,并通过时间分析和患者队列分析来描述PMA的频率。
使用国际疾病分类第10版编码,在2016年至2020年期间的国家(全国)住院患者样本(NIS)数据库中识别RSIE患者。对接受PMA治疗的患者的RSIE住院临床特征和时间趋势进行了描述。
在5年的研究期间,美国估计有117,955例与RSIE相关的住院病例,其中1675例包括PMA。值得注意的是,RSIE的PMA发生率从2016年的0.56%增至2020年的2.62%,增长了4.7倍。接受PMA治疗的RSIE患者较为年轻(中位年龄36.5岁),合并症较少(中位Charlson合并症指数为0.6)。值得注意的是,36.1%的患者有丙型肝炎感染史,而只有9.9%的患者有心血管植入式电子设备。金黄色葡萄球菌是主要病原体(61.8%)。在PMA住院期间,分别有18.2%和8.4%的患者同时进行了经静脉导线拔除和心脏瓣膜手术。中位住院时间为19.0天,住院死亡率为6.0%。
美国PMA手术数量的显著增加表明,这种新的治疗选择已被视为RSIE特定病例中的一种有用工具。需要开展更多工作,以更好地明确该手术的适应证及其疗效和安全性。